Clinical Trial: Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07632677) titled 'Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD' on May 23.

Brief Summary: This observational study aims to evaluate a new diagnostic tool, the Liver Inflammation Index, in detecting Metabolic Dysfunction-Associated Steatohepatitis (MASH) among adults who have both Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).

Study Start Date: May 15

Study Type: OBSERVATIONAL

Condition: Type 2 Diabetes Mellitus (T2DM) MASH - Metabolic Dysfunction-Associated Steatohepatitis Metabolic Dysfunction-associated Fatty Liver Disease

Intervention: DIAGNOSTIC_T...